ArticleNanoscale advances2025
Passivation, phase, and morphology control of CdS nanocrystals probed using fluorinated aromatic amines and solid-state NMR spectroscopy.
Article in Nanoscale advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- CdS-Based Photocatalysts for Antimicrobial Applications: From Quantum Dots to Z-Scheme Heterojunctions-Mechanisms, Challenges, and Future Perspectives.Molecules (Basel, Switzerland) · 2026Review
- Metal Ion Dynamic Nuclear Polarization in Mn(II)-Doped CdS Nanocrystals: Atomic-Scale Investigation of the Dopant and Its Host.ACS nano · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanocrystals are widely explored for a range of medical, imaging, sensing, and energy conversion applications. CdS nanocrystals have been reported as excellent photocatalysts, with thin film CdS also highly important in photovoltaic devices. To optimise properties of nanocrystals, control over phase, facet, and morphology are vital. Here, CdS nanocrystals were synthesised by the solvothermal decomposition of a Cd xanthate single source precursor. To attempt to control CdS nanocrystal surfaces and morphology, the solvent used in the nanocrystal synthesis was altered from pure trioctylphosphine oxide (TOPO) to a mixed TOPO : fluorinated aromatic amine (3-fluorobenzyl amine (3-FlBzAm) or 3-fluoroaniline (3-FlAn)), where
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.